Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma

Published:2018-06-08 Issue:44 Volume:9 Page:27471-27486
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Takashima Yasuo¹,Sasaki Yasushi²,Hayano Azusa¹,Homma Jumpei³,Fukai Junya⁴,Iwadate Yasuo⁵,Kajiwara Koji⁶,Ishizawa Shin⁷,Hondoh Hiroaki³,Tokino Takashi⁸,Yamanaka Ryuya¹

Affiliation:

1. Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

2. Center for Medical Education, Sapporo Medical University, Sapporo, Japan

3. Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan

4. Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan

5. Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan

6. Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Yamaguchi, Japan

7. Department of Pathology, Toyama Prefectural Central Hospital, Toyama, Japan

8. Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study;Signal Transduction and Targeted Therapy;2024-09-04

2. Updates of primary central nervous system lymphoma;Therapeutic Advances in Hematology;2024-01

3. Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets;Modern Pathology;2023-12

4. Extranodal lymphoma: pathogenesis, diagnosis and treatment;Molecular Biomedicine;2023-09-18

5. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients;Frontiers of Medicine;2023-07-07